Segments - Net Sales and Adjusted EBITDA of Reportable Segments (Detail) - USD ($) $ in Millions		3 Months Ended		6 Months Ended
		Jun. 30, 2016	Jun. 30, 2015	Jun. 30, 2016	Jun. 30, 2015
Segment Reporting Information [Line Items]
Net sales		$ 1,727.0	$ 1,785.0	$ 3,317.6	$ 3,531.4
Adjusted EBITDA Margin		17.70%	17.20%	16.50%	16.80%
Non-U.S. GAAP Total Company Adjusted EBITDA		$ 305.6	$ 307.6	$ 548.7	$ 591.8
Operating Segments [Member] | Food Care [Member]
Segment Reporting Information [Line Items]
Net sales		802.3	846.6	1,567.0	1,726.4
Adjusted EBITDA		$ 162.8	$ 173.7	$ 310.6	$ 364.2
Adjusted EBITDA Margin		20.30%	20.50%	19.80%	21.10%
Operating Segments [Member] | Diversey Care [Member]
Segment Reporting Information [Line Items]
Net sales		$ 531.9	$ 535.0	$ 973.3	$ 1,002.9
Adjusted EBITDA		$ 86.2	$ 69.0	$ 122.5	$ 110.1
Adjusted EBITDA Margin		16.20%	12.90%	12.60%	11.00%
Operating Segments [Member] | Product Care [Member]
Segment Reporting Information [Line Items]
Net sales	[1]	$ 374.2	$ 383.9	$ 741.4	$ 763.8
Adjusted EBITDA	[1]	$ 78.8	$ 79.6	$ 155.9	$ 156.0
Adjusted EBITDA Margin		21.10%	20.70%	21.00%	20.40%
Other [Member]
Segment Reporting Information [Line Items]
Net sales	[1]	$ 18.6	$ 19.5	$ 35.9	$ 38.3
Adjusted EBITDA	[1]	$ (22.2)	$ (14.7)	$ (40.3)	$ (38.5)
Product Concentration Risk [Member] | Net Sales [Member] | Operating Segments [Member] | Food Care [Member]
Segment Reporting Information [Line Items]
Concentration risk percentage		46.50%	47.40%	47.20%	48.90%
Product Concentration Risk [Member] | Net Sales [Member] | Operating Segments [Member] | Diversey Care [Member]
Segment Reporting Information [Line Items]
Concentration risk percentage		30.80%	30.00%	29.30%	28.40%
Product Concentration Risk [Member] | Net Sales [Member] | Operating Segments [Member] | Product Care [Member]
Segment Reporting Information [Line Items]
Concentration risk percentage		21.70%	21.50%	22.30%	21.60%

[1] As of January 1, 2016, our Kevothermal business was moved from Other to our Product Care Segment. This resulted in a reclassification of $2.9 million of net sales and $0.6 million of adjusted EBITDA for the three months ended June 30, 2015 and $5.7 million of net sales and $1.4 million of adjusted EBITDA for the six months ended June 30, 2015.